EUTM file information

018723516

InstilBio


June 26, 2022

Trademark Summary

The trademark application InstilBio was filed by Instil Bio, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on July 21, 2022, and it was registered by office on October 28, 2022 without any oppositions.

The application was filed in English (German was selected as the second language).

Appointment and Replacement of representative of the trademark registration was recorded on November 15, 2022. Change of name and professional address of the trademark registration was recorded on January 26, 2023. Change of name and address of the trademark registration was recorded on April 27, 2023. Appointment and Replacement of representative of the trademark registration was recorded on December 17, 2023.


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Cells for medical or clinical use
    2. Cells featuring digested tumor tissue and increased lymphocytes for medical or clinical use
    3. Biological preparations for the treatment of cancer and cellular disorders
    4. Reagents for medical use
    5. Drug delivery agents consisting of compounds that facilitate the preservation and delivery of a wide range of pharmaceuticals.
  • The mark was filed in class 10 with Medical specimen collection devices in the nature of bags and vials for the collection of biological tissue.
  • The mark was filed in class 40 with Custom manufacture of biological preparations, pharmaceutical preparations and cell therapy preparations.
  • The mark was filed in class 41 with following description of goods:
    1. Providing non-downloadable publications in the nature of articles, newsletters and brochures in the fields of cancer treatment and cell therapies
    2. Educational services, namely, conducting programs in the field of cancer treatment and cell therapies
    3. Educational services, namely, arranging and conducting classes, seminars and workshops in the fields of cancer treatment and cell therapies.